Effect of nitric oxide on the differentiation of fibroblasts into myofibroblasts in the Peyronie's fibrotic plaque and in its rat model

Nitric Oxide - Biology and Chemistry

Volumn 7, Issue 4, 2002, Pages 262-276

  Vernet, Dolores ^a   Ferrini, Monica G ^a   Valente, Eliane G ^a   Magee, Thomas R ^a,b   Bou Gharios, George ^c   Rajfer, Jacob ^a,b   Gonzalez Cadavid, Nestor F ^a,b  

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

smooth muscle actin; Collagen I; Fibrosis; Heme oxygenase I; Inducibie nitric oxide synthase; Myofibroblast; Nitric oxide; Peyronie's disease L NIL; ROS; TGF 1; Tunica albuginea

Indexed keywords

ACTIN; BETA GALACTOSIDASE; CELL MARKER; COLLAGEN; COLLAGEN TYPE 1; CYTOKINE; LYSINE DERIVATIVE; N ACETYL S NITROSOPENICILLAMINE; NITRIC OXIDE; VIMENTIN; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE; NOS2 PROTEIN, RAT; NOS2A PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL ASSAY; CELL COUNT; CELL CULTURE; CELL DIFFERENTIATION; CONTROLLED STUDY; DISEASE MODEL; ENZYME ACTIVITY; ENZYME INHIBITION; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MYOFIBROBLAST; NONHUMAN; PEYRONIE DISEASE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RAT; SMOOTH MUSCLE; TISSUE HOMOGENATE; TUNICA ALBUGINEA; ANIMAL; BIOSYNTHESIS; DRUG ANTAGONISM; DRUG EFFECT; ENZYME INDUCTION; FIBROSIS; FISCHER 344 RAT; METABOLISM; MYOBLAST; PATHOLOGY; PHYSIOLOGY;

ANIMALIA;

ACTINS; ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; COLLAGEN TYPE I; DISEASE MODELS, ANIMAL; ENZYME INDUCTION; FIBROBLASTS; FIBROSIS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MUSCLE, SMOOTH; MYOBLASTS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PENILE INDURATION; RATS; RATS, INBRED F344; VIMENTIN;

EID: 0036434536     PISSN: 10898603     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1089-8603(02)00124-6     Document Type: Article

References (66)

1. M.G. Ferrini, D. Vernet, T.R. Magee, A. Shahed, A. Qian, J. Rajfer, N.F. Gonzalez-Cadavid, Antifibrotic role of inducible nitric oxide synthase (iNOS), Nitric Oxide 6 (2002) 283-299.
2. F.S. Shihab, H. Yi, W.M. Bennett, T.F. Andoh, Effect of nitric oxide modulation on TGF-beta1 and matrix proteins in chronic cyclosporine nephrotoxicity, Kidney Int. 58 (2000) 1174-1185.
3. C.M. Hogaboam, C.S. Gallinat, C. Bone-Larson, S.E. Chensue, N.W. Lukacs, R.M. Strieter, S.L. Kunkel, Collagen deposition in a non-fibrotic lung granuloma model after nitric oxide inhibition, Am. J. Pathol. 153 (1998) 1861-1872.
4. T. Takizawa, M. Gu, A.V. Chobanian, P. Brecher, Effect of nitric oxide on DNA replication induced by angiotensin II in rat cardiac fibroblasts, Hypertension 30 (1997) 1035-1040.
5. C. Chatziantoniou, J.J. Boffa, R. Ardaillou, J.C. Dussaule, Nitric oxide inhibition induces early activation of type I collagen gene in renal resistance vessels and glomeruli in transgenic mice. Role of endothelin, J. Clin. Invest. 101 (1998) 2780-2789.
6. M. Criado, O. Flores, M.J. Vazquez, A. Esteller, Role of prostanoids and nitric oxide inhibition in rats with experimental hepatic fibrosis, J. Physiol. Biochem. 56 (2000) 181-188.
7. J.J. Momssey, S. Ishidoya, R. McCracken, S. Klahr, Nitric oxide generation ameliorates the tubulointerstitial fibrosis of obstructive nephropathy, J. Am. Soc. Nephrol. 1 (1996) 2202-2212.
8. P. Babal, O. Pechanova, I. Bernatova, S. Stvrtina, Chronic inhibition of NO synthesis produces myocardial fibrosis and arterial media hyperplasia, Histol. Histopathol. 12 (1997) 623-629.
9. J.J. Boffa, P.-L. Tharaux, S. Placier, R. Ardaillou, J.-C. Dussaule, C. Chatziantoniou, Angiotensin II activates collagen I gene in the renal vasculature of transgenic mice during inhibition of nitric oxide synthesis. Evidence for an endothelin-mediated mechanism, Circulation 100 (1999) 1901-1908.
10. O. Pechanova, I. Bernatova, V. Pelouch, P. Babal, L-NAME-induced protein remodeling and fibrosis in the rat heart, Physiol. Res. 48 (1999) 353-362.
11. D. Hochberg, C.W. Johnson, J. Chen, D. Cohen, J. Stern, E.D. Vaughan, D. Poppas, D. Felsen, Interstitial fibrosis of unilateral ureteral obstruction is exacerbated in kidneys of mice lacking the gene for inducible nitric oxide synthase, Lab. Invest. 80 (2000) 1721-1728.
12. A.J. Chu, J.K. Prasad, Up-regulation by human recombinant transforming growth factor beta-1 of collagen production in cultured dermal fibroblasts is mediated by the inhibition of nitric oxide signaling, J. Am. Coll. Surg. 188 (1999) 271-280.
13. M.A. Rizvi, P.R. Myers, Nitric oxide modulates basal and eridothelin-induced coronary artery vascular smooth muscle cell proliferation and collagen levels, J. Mol. Cell. Cardiol 29 (1997) 79-1789.
14. S.J. Kim, J.W. Ju, C.D. Oh, Y.M. Yoon, W.K. Song, J.H. Kim, Y.J. Yoo, O.S. Bang, S.S. Kang, J.S. Chun, ERIC-1/2 and p38 kinase oppositely regulate nitric oxide-induced apoptosis of chondrocytes in association with p53, caspase-3, and differentiation status, J. Biol. Chem. 277 (2002) 1332-1339.
15. P.A. Craven, R.K. Studer, J. Felder, S. Phillips, F.R. DeRubertis, Nitric oxide inhibition of transforming growth factor-beta and collagen synthesis in mesangial cells, Diabetes 46 (1997) 671-681.
16. A. Casini, E. Ceni, R. Salzano, P. Biondi, M. Parola, A. Galli, M. Foschi, A. Caligiuri, M. Pinzani, C. Surrenti, Neutrophil-derived superoxide anion induces lipid peroxidation and stimulates collagen synthesis in human hepatic stellate cells: Role of nitric oxide, Hepatology 25 (1997) 61-367.
17. M.W. Owens, S.A. Milligan, M.B. Grisham, Inhibition of pleural mesothelial cell collagen synthesis by nitric oxide, Free Radic. Biol. Med. 21 (1996) 601-607.
18. V. Kolpakov, D. Gordon, T.J. Kulik, Nitric oxide-generating compounds inhibit total protein and collagen synthesis in cultured vascular smooth muscle cells, Circ. Res. 76 (1995) 305-309.
19. H. Trachtman, S. Futterweit, P. Singhal, Nitric oxide modulates the synthesis of extracellular matrix proteins in cultured rat mesangial cells, Biochem. Biophys. Res. Commun. 207 (1995) 120-125.
20. H.P. Shi, D. Most, D.T. Efron, U. Tantry, M.H. Fischel, A. Barbul, The role of iNOS in wound healing, Surgery 130 (2001) 225-229.
21. F.J. Thornton, M.R. Schaffer, M.B. Witte, L.L. Moldawer, S.L. MacKay, A. Abouhamze, C.L. Tannahill, A. Barbul, Enhanced collagen accumulation following direct transfection of the inducible nitric oxide synthase gene in cutaneous wounds, Biochem. Biophys. Res. Commun. 246 (1998) 654-659.
22. M.B. Witte, F.J. Thornton, D.T. Efron, A. Barbul, Enhancement of fibroblast collagen synthesis by nitric oxide, Nitric Oxide 4 (2000) 572-582.
23. W.J. Hellstrom, T.J. Bivalacqua, Peyronie's disease: Etiology, medical, and surgical therapy, J. Androl. 21 (2000) 347-354.
24. N.F. Gonzalez-Cadavid, T.R. Magee, M. Ferrini, A. Qian, D. Vernet, J. Rajfer, Gene expression in Peyronie's disease, Int. J. Impot. Res. 14 (2002) 1-12.
25. T.J. Bivalacqua, E.K. Diner, T.E. Novak, Y. Vohra, S.C. Sikka, H.C. Champion, P.J. Kadowitz, W.J. Hellstrom, A rat model of Peyronie's disease associated with a decrease in erectile activity and an increase in inducible nitric oxide synthase protein expression, J. Urol. 163 (2000) 1992-1998.
26. G. Poli, Pathogenesis of liver fibrosis: Role of oxidative stress, Mol. Aspects Med. 21 (2002) 49-98.
27. G. Svegliati-Baroni, S. Saccomanno, H. van Goor, P. Jansen, A. Benedetti, H. Moshage, Involvement of reactive oxygen species and nitric oxide radicals in activation and proliferation of rat hepatic stellate cells, Liver 21 (2001) 1-12.
28. H.P. Ehrlich, Scar contracture: Cellular and connective tissue aspects in Peyronie's disease, J. Urol. 157 (1997) 316-319.
29. D.W. Powei, R.C. Mifflin, J.D. Valentich, S.E. Ceowe, J.I. Saada, A.B. West, Myofibroblasts. Paracrine cells important in health and disease, Am. J. Physiol. 277 (1999) C1-C19.
30. G.A. Walker, I.A. Guerrero, L.A. Leinwand, Myofibroblasts: Molecular crossdressers, Curr. Top Dev. Biol. 51 (2001) 91-107.
31. G. Serini, G. Gabbiani, Mechanisms of myofibroblast activity and phenotypic modulation, Exp. Cell Res. 250 (1999) 273-283.
32. J.J. Tomasek, M.B. Vaughan, C.J. Haaksma, Cellular structure and biology of Dupuyrren's disease, Hand Clin. 15 (1999) 21-34.
33. I.S. Yi, G. Johnson, M.S. Moneim, Etiology of Dupuytren's disease, Hand Clin. 15 (1999) 43-51.
34. K.D. Somers, D.M. Dawson, G.L. Wright Jr., M.S. Leffell, M.J. Rowe, G.G. Bluemink, J.S. Vande Berg, S.H. Gleischman, C.J. Devine Jr., C.E. Horton, Cell culture of Peyronie's disease plaque and normal penile tissue, J. Urol. 127 (1982) 585-588.
35. C.J. Davis, The microscopic pathology of Peyronie's disease, J. Urol. 157 (1997) 282-284.
36. M.S. Anderson, T.V. Shankey, T. Lubrano, J.P. Mulhall, Inhibition of Peyronie's plaque fibroblast proliferation by biologic agents, Int. J. Impot. Res. 12 (Suppl 3) (2000) S25-S31.
37. J.P. Mulhall, J. Thom, T. Lubrano, T.V. Shankey, Basic fibroblast growth factor expression in Peyronie's disease, J. Urol. 165 (2001) 419-423.
38. M.B. Grisham, D. Jourd'Heuil, D.A. Wink, Nitric oxide I. Physiological chemistry of nitric oxide and its metabolites: Implications in inflammation, Am. J. Physiol. 276 (1999) G315-G321.
39. M. Ferrini, T.R. Magee, D. Vernet, C. Hayden, J. Rajfer, N.F. Gonzalez-Cadavid, Aging-related expression of inducible nitric oxide sunthase (iNOS) and cytotoxicity markers in the rat penis, Biol. Reprod. 64 (2001) 974-982.
40. M. Ferrini, C. Wang, R.S. Swerdloff, A.P. Sinha Hikim, J. Rajfer, N.F. Gonzalez-Cadavid, Aging-related increased expression of inducible nitric oxide synthase and cytotoxicity markers in rat hypothalamic regions associated with male reproductive function, Neuroendocrinology 74 (2001) 1-11.
41. N. Peunova, V. Scheinker, H. Cline, G. Enikolopov, Nitric oxide is an essential negative regulator of cell proliferation in Xenopus brain, J. Neurosci. 21 (2001) 8809-8818.
42. V. Krischel, D. Bruch-Gerharz, C. Suschek, K.D. Kroncke, T. Ruzicka, V. Kolb-Bachofen, Biphasic effect of exogenous nitric oxide on proliferation and differentiation in skin derived keratinocytes but not fibroblasts, J. Invest. Dermatol. 111 (1998) 286-291.
43. M.C. O'Shaughnessy, J.M. Polak, F. Afzal, M.V. Hukkarien, P. Huang, L. Maclntyre, L.D. Buttery, Nitric oxide mediates 17-beta-estradiol-stimulated human and rodent osteoblast proliferation and differentiation, Biochem. Biophys. Res. Commun. 277 (2000) 604-610.
44. E. Rodriguez-Martin, M.J. Casarejos, E. Bazan, S. Canals, A.S. Herranz, M.A. Mena, Nitric oxide induces differentiation in the NB69 human catecholamine-rich cell line, Neuropharmacology 39 (2000) 2090-2100.
45. T.R. Magee, A. Qian, J. Rajfer, F.C. Sander, L. Levine, N.F. Gonzalez-Cadavid, Gene expression profiles in the Peyronie's disease plaque, Urology 59 (2002) 451-457.
46. C. Grupp, G.A. Muller, Renal fibroblast culture, Exp. Nephrol. 7 (1999) 377-385.
47. A. Hung, D. Vernet, T. Rajavashisht, J.A. Rodriguez, J. Rajfer, N.F. Gonzalez-Cadavid, Expression of the inducible nitric oxide synthase in smooth muscle cells from the rat penile corpora cavernosa, J. Androl. 16 (1995) 469-481.
48. A.I. El-Sakka, H.M. Hassoba, R.M. Chui, R.S. Bhatnagar, R. Dahiya, T.F. Lue, An animal model of Peyronie's-like condition associated with an increase of transforming growth factor beta mRNA and protein expression, J. Urol. 158 (1997) 2284-2290.
49. J.R. Connor, P.T. Maning, S.L. Settle, W.M. Moore, G.M. Jerome, R.K. Webber, F.S. Tjoeng, M.G. Currie, Suppression of adjuvant-induced arthritis by selective inhibition of inducible nitric oxide synthase, Eur. J. Pharmacol. 273 (1995) 15-24.
50. S. De Val, M. Ponticos, T.T. Antoniv, D.J. Wells, D. Abraham, T. Partridge, G. Bou-Gharios, Identification of the key regions within the mouse pro-alpha 2(I) collagen gene far-upstream enhancer, J. Biol. Chem. 277 (2002) 9286-9292.
51. T.R. Magee, M. Ferrini, H. Garban, D. Vernet, K. Mitani, J. Rajfer, N.F. Gonzalez-Cadavid, Gene therapy of erectile dysfunction in the rat with penile neuronal nitric oxide synthase cDNA, Biol. Reprod. in press 2002.
52. M.A. Badalamente, L.C. Hurst, The biochemistry of Dupuytren's disease, Hand Clin. 15 (1999) 35-42.
53. J. Chesney, R. Bucala, Peripheral blood fibrocytes: Mesenchymal precursor cells and the pathogenesis of fibrosis, Curr. Rheumatol. Rep. 2 (2000) 501-505.
54. M.G. Ferrini, D. Vernet, A. Qian, T.R. Magee, S. Bhasin, J. Rajfer, N.F. Gonzalez-Cadavid, Inhibition of Inducible Nitric Oxide Synthase (iNOS) Activity is Associated with Myostatin Expression and Myofibroblast Differentiation in the Peyronie's Fibrotic Plaque, to be submitted 2001.
55. M. Cavicchi, L. Gibbs, B.J. Whittle, Inhibition of inducible nitric oxide synthase in the human intestinal epithelial cell line, DLD-1, by the inducers of heme oxygenase 1, bismuth salts, heme, and nitric oxide donors, Gut. 47 (2000) 771-778.
56. H. Zhang, C. Snead, J.D. Catravas, Nitric oxide differentially regulates induction of type II nitric oxide synthase in rat vascular smooth muscle cells versus macrophages, Arterioscler. Thromb. Vase. Biol. 21 (2001) 529-535.
57. S. Kanno, P.C. Lee, Y. Zhang, C. Ho, B.P. GriNth, L.L. Shears 2nd, T.R. Billiar, Attenuation of myocardial ischemia/reperfusion injury by superinduction of inducible nitric oxide synthase, Circulation 101 (2000) 2742-2748.
58. J.X. Chen, L.C. Berry, M. Tanner, M. Chang, R.P. Myers, B. Meyrick, Nitric oxide donors regulate nitric oxide synthase in bovine pulmonary artery endothelium, J. Cell Physiol. 186 (2001) 116-123.
59. K. Kasai, Y. Hattori, N. Banba, S. Hattori, S. Motohashi, S. Shimoda, N. Nakanishi, S.S. Gross, Induction of tetrahydrobiopterin synthesis in rat cardiac myocytes: Impact on cytokine-induced NO generation, Am. J. Physiol. 273 (1997) H665-H672.
60. N.N. Kim, S. Villegas, S.R. Summerour, F.J. Villarreal, Regulation of cardiac fibroblast extracellular matrix production by bradykinin and nitric oxide, J. Mol. Cell. Cardiol. 31 (1999) 457-466.
61. M.G. Pessanh, C.A. Mandarim-de-Lacerda, Myofibroblast accumulation in healing rat myocardium due to long-term low-dosage nitric oxide synthesis inhibition, Exp. Toxicol. Pathol. 52 (2000) 192-194.
62. J.S. Duffield, L.P. Erwig, X. Wei, F.Y. Liew, A.J. Rees, J.S. Savill, Activated macrophages direct apoptosis and suppress mitosis of mesangial cells, J. Immunol. 164 (2000) 2110-2119.
63. A. Shukla, A.M. Rasik, R. Shankar, Nitric oxide inhibits wounds collagen synthesis, Mol. Cell Biochem. 200 (1999) 27-33.
64. M. Cao, A. Westerhausen-Larson, C. Niyibizi, K. Kavalkovich, H.I. Georgescu, C.F. Rizzo, P.A. Hebda, M. Stefanovic-Racic, C.H. Evans, Nitric oxide inhibits the synthesis of type-II collagen without altering Col2A1 mRNA abundance: Prolyl hydroxylase as a possible target, Biochem. J. 324 (1997) 305-310.
65. T. Okamoto, T. Akaike, T. Nagano, S. Miyajima, M. Suga, M. Ando, K. Ichimori, H. Maeda, Activation of human neutrophil procollagenase by nitrogen dioxide and peroxynitrite: A novel mechanism for procollagenase activation involving nitric oxide, Arch. Biochem. Biophys. 342 (1997) 261-274.
66. H.Y. Zhang, M. Gharaee-Kermani, S.H. Phan, Regulation of lung fibroblast alpha-smooth muscle actin expression, contractile phenotype, and apoptosis by IL-1beta, J. Immimol. 158 (1997) 1392-1399.